Diagnostics and treatment of cutaneous and mucocutaneous Leishmania infections: expert recommendations
Open Access
- 24 February 2026
- journal article
- Published by Osterreichische Akademie der Wissenschaften, Verlag in SKINdeep
- Vol. 2, e182644
Abstract
Cutaneous and mucosal/mucocutaneous Leishmania infections may present with very different clinical signs depending on the involved species, the site of infection and the immune status of the host. Leishmania species are intracellular protozoan pathogens transmitted by phlebotomine sand flies, of which over 20 species infecting humans have been described. Leishmania infections are rather common, with an estimated number of one million new cases per year worldwide. The countries with the highest incidence of cutaneous leishmaniasis cases are Afghanistan, Algeria, Brazil, Colombia, Iraq, Libya, Pakistan, Peru, Syria, and Tunisia, while most mucocutaneous cases occur in Bolivia, Brazil, Ethiopia, and Peru. The disease is also endemic in all Southern European countries, with approximately 700 autochthonous human cases reported each year and many more asymptomatic infections. Central Europe is considered non-endemic for the disease; however, epidemiological patterns are affected by travel habits, migration, globalization, and climate change. This review focuses on the diagnostic procedures and treatment options for cutaneous and mucocutaneous Leishmania infections.Keywords
This publication has 47 references indexed in Scilit:
- Efficacy of photodynamic therapy in cutaneous leishmaniasis: A systematic reviewPhotodiagnosis and Photodynamic Therapy, 2023
- Sand flies: Basic information on the vectors of leishmaniasis and their interactions with Leishmania parasitesCommunications Biology, 2022
- Association of miltefosine with granulocyte and macrophage colony-stimulating factor (GM-CSF) in the treatment of cutaneous leishmaniasis in the Amazon region: A randomized and controlled trialInternational Journal of Infectious Diseases, 2021
- Application of laser for treatment of cutaneous leishmaniasis: a review of literatureLasers in Medical Science, 2020
- Fractionated illumination improves the treatment outcomes of photodynamic therapy for high grade cutaneous leishmaniasisPhotodiagnosis and Photodynamic Therapy, 2020
- Use of the intramuscular route to administer pentamidine isethionate in Leishmania guyanensis cutaneous leishmaniasis increases the risk of treatment failureTravel Medicine and Infectious Disease, 2018
- Liposomal amphotericin B in comparison to sodium stibogluconate for Leishmania braziliensis cutaneous leishmaniasis in travelersJournal of the American Academy of Dermatology, 2013
- Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasisActa Tropica, 2004
- A randomized clinical trial of topical paromomycin versus oral ketoconazole for treating cutaneous leishmaniasis in TurkeyInternational Journal of Dermatology, 1997
- Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: A double-blind control studyJournal of the American Academy of Dermatology, 1992